FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug
The FDA’s Allergenic Products Advisory Committee voted 7-2 in favor of supporting the efficacy profile of Palforzia, or AR101. Some committee members expressed concerns about...
Tag: wellpoint
New startup aims to help investors avoid debacles through medical diligence
If they hope to grab a piece of the health-spending pie, investors and entrepreneurs may […] Source link...
Groupons for medical treatment? Welcome to today’s U.S. healthcare
Groupon deals on healthcare such as chest CT or lung, heart and full-body scans are popping up across Atlanta, as well as in Oklahoma and...
2019 is the year of the digital health IPO but will it last?
After a relatively quiet IPO market, 2019 has emerged as the year of the digital health IPO with Health Catalyst, Livongo Health, Phreesia, and Change...
Another myeloma drug with same target as CAR-Ts shows successful Phase II results
Without providing details, GlaxoSmithKline said its trial of BCMA-targeting belantamab mafodotin was positive. The company plans to submit for regulatory approvals later this year –...
Trump officials look to ease privacy rules around addiction treatment records
Trump officials argue that current regulation has not kept up with the times and the necessity of coordinated approaches to addressing the opioid epidemic. Source...
Documents reveal conflict between VA and unelected Trump advisors
Marvel Chairman Isaac Perlmutter, lawyer Marc Sherman and physician Bruce Moscovitz – who have associated with President Trump through their membership in Trump’s Mar-a-Lago resort...
Dental company SmileDirectClub files to go public
The company offers personalized 3-D printed clear aligners – essentially a form of transparent plastic braces – in a direct to consumer model that it...
FDA approves first drug for blood disorder myelofibrosis since 2011
The agency said Friday that it had approved Celgene’s Inrebic (fedratinib), the first new drug approved for the disease – a type of rare blood...
A majority of large employers want to expand Medicare, survey says
A recent survey from the National Business Group on Health found that among large employers, 55 percent were in favor of expanding Medicare. Source link...
Exclusive: Director of TMC Venture Fund has been let go
Juliana Garaizar’s removal marks the second time in the past 12 months that TMC’s leadership is making executive changes at the very top of organizations...
Roche drug is third to win biomarker-driven cancer approval from FDA
On Thursday, Roche’s Rozlytrek won simultaneous FDA labels for NTRK fusion-positive solid tumors and ROS1-positive non-small cell lung cancer. Source link...
CMS is bringing star quality ratings to health exchange plans
Rolling out the ratings nationwide is part of the Trump Administration’s larger initiative to inject cost and quality transparency into the healthcare system. Source link...
Evidation Health and Eli Lilly study uses Apple wearables and apps to predict cognitive impairment
Early results from a study conducted by Evidation Health, Eli Lilly and Apple have shown the ability to detect cognitive decline and mild Alzheimer’s disease...
Doctors falsely argue plans to remedy surprise medical bills will ‘shred’ the safety net
The surprise medical bill legislation is an effort to help consumers who generally mistakenly thought they were getting health services covered by their insurers but...
Johnson & Johnson’s new antidepressant could face structural barriers to uptake
The FDA approved Spravato in March, but a new paper in JAMA examines some of the barriers inherent in the practice and reimbursement of psychiatry...
bluebird working to open European gene therapy sites, but high price could be a hindrance
An analyst wrote that bluebird bio would likely launch Zynteglo first in Germany, followed by other countries, but scaled back sales forecasts due to the...
Care navigation company Accolade acquires provider data startup MD Insider
The acquisition enabled the development of Accolade Total Care, a product meant to ease the headache of finding a high-quality physician by making provider quality...
Expert panel to review Nektar drug delayed as FDA postpones opioid meetings
In a regulatory filing, the company said that the postponement was not unique to NKTR-181, though it may result in a delay in the FDA’s...
UHS agrees to $127M DOJ to settle behavioral health investigation
Alongside the payment, which resolves the civil aspect probe from the DOJ and a number of states that UHS incorrectly billed Medicare and Medicaid programs,...